AwesomeAvani

MGNX a biotech company gets new "Outperform" LONG

Largo
AwesomeAvani Actualizado   
BATS:MGNX   MacroGenics, Inc.
MGNX as a biotech company makes antibodies against certain cancers. The antibody is tagged to

chemotherapy molecules and then heads off looking for cancer cells to which it has a strong

affinity. So much for the science. MGNX just got upgraded and the new target is $ 16.00 about

25% upside. Biotech and healthcare are projected hot sectors this year.

On the 15 minute chart price jumped about 12% in the past week and bounced down toward

the anchored mean VWAP and is well situated for a long entry. the dual TF RSI indicator

shows both lines crossing the 50 level in early bullish momentum off the bounce.

It is continually hitting new past year highs at a great trend angle and is on pace to hit 400% for

an annual return. There is no option play here as the volume is minimal and liquidity is absent.

The all-time high is about $32 so there is plenty of room above the analyst's target over the long

term. Price has moved 12X the S & P YTD certainly a sign of relative strength.
Operación activa:
MGNX up 10% for the week overall. Holding full position. This is expected to be

a long-duration swing trade. When the position is up 10% I will close 20% of the

position.
Operación activa:
Trade is up 15% - 20% of the position is closed trailing stop loss of 5% on the remaining 80% now a risk-free trade.
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.